MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ResMed Company Profile (NYSE:RMD)

Consensus Ratings for ResMed (NYSE:RMD) (?)
Ratings Breakdown: 2 Sell Rating(s), 5 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Hold (Score: 2.27)
Consensus Price Target: C$57.92 (8.40% downside)

Analysts' Ratings History for ResMed (NYSE:RMD)
Show:
DateFirmActionRatingPrice TargetActions
6/27/2016Needham & Company LLCDowngradeHold -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016BMO Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016MacquarieUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Citigroup Inc.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Piper JaffrayDowngradeOverweight -> Neutral$65.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016BarclaysInitiated CoverageUnderweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Credit SuisseUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Deutsche BankUpgradeSell -> Hold$53.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015Goldman SachsUpgradeNeutral -> Conviction-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Jefferies GroupSet Price TargetHold$65.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Bank of AmericaDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015Northland SecuritiesBoost Price TargetHold -> Under Perform$40.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for ResMed (NYSE:RMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/26/2016Q316$0.69$0.68$455.32 million$453.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016Q216$0.66$0.69$445.46 million$454.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q116$0.59$0.58$406.26 million$411.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q415$0.65$0.68$436.27 million$453.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q315$0.65$0.65$425.76 million$422.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2015Q215$0.62$0.64$408.20 million$423.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q115$0.58$0.58$375.00 million$380.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q414$0.66$0.64$433.42 million$415.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q314$0.64$0.63$401.00 million$397.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2014Q214$0.63$0.60$398.09 million$384.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q114$0.58$0.56$372.28 million$357.66 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q4 2013$0.62$0.62$410.89 million$414.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q3 2013$0.58$0.58$386.76 million$383.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2013Q2 2013$0.51$0.53$363.76 million$376.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$0.46$0.49ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.49$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.41$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$0.38$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2011$0.35$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.37$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.35$0.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.36$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for ResMed (NYSE:RMD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.70$0.73$0.72
Q2 20162$0.75$0.75$0.75
Q3 20161$0.68$0.68$0.68
Q4 20163$0.74$0.76$0.75
Q1 20172$0.68$0.77$0.73
Q2 20172$0.75$0.82$0.79
Q3 20171$0.75$0.75$0.75
Q4 20171$0.80$0.80$0.80
(Data provided by Zacks Investment Research)
Current Dividend Information for ResMed (NYSE:RMD)
Annual Dividend:$1.20
Dividend Yield:1.90%
Payout Ratio:45.28%
Dividend Growth:50.50% (3 Year Average)

Dividend History for ResMed (NYSE:RMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/26/2016quarterlyC$0.302.12%5/17/20165/19/20166/16/2016Tweet This Announcement  Share This Announcement on StockTwits
1/21/2016quarterlyC$0.302.08%2/9/20162/11/20163/17/2016Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015quarterlyC$0.302.13%11/17/201511/19/201512/17/2015Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015quarterlyC$0.302.07%8/18/20158/20/20159/17/2015Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015quarterlyC$0.281.7%5/19/20155/21/20156/18/2015Tweet This Announcement  Share This Announcement on StockTwits
1/23/2015quarterlyC$0.281.72%2/10/20152/12/20153/19/2015Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014quarterlyC$0.282.17%11/18/201411/20/201412/18/2014Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014quarterlyC$0.282.25%8/19/20148/21/20149/18/2014Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014quarterlyC$0.252.11%5/16/20145/20/20146/17/2014Tweet This Announcement  Share This Announcement on StockTwits
1/24/2014quarterlyC$0.252.28%2/14/20142/19/20143/19/2014Tweet This Announcement  Share This Announcement on StockTwits
10/25/2013quarterlyC$0.252.02%11/15/201311/19/201312/18/2013Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013quarterlyC$0.252.09%8/16/20138/20/20139/17/2013Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013quarterlyC$0.171.44%5/17/20135/21/20136/18/2013Tweet This Announcement  Share This Announcement on StockTwits
1/25/2013quarterlyC$0.171.41%2/14/20132/19/20133/19/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for ResMed (NYSE:RMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/15/2016James HollingsheadInsiderSell4,458C$59.40C$264,805.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Michael J FarrellCEOSell5,975C$59.63C$356,289.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Peter C FarrellDirectorSell20,000C$59.82C$1,196,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016David PendarvisInsiderSell6,000C$59.41C$356,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Michael J FarrellCEOSell5,975C$57.64C$344,399.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Peter C FarrellDirectorSell20,000C$55.90C$1,118,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016David PendarvisInsiderSell6,000C$56.02C$336,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016Michael J FarrellCEOSell5,975C$59.34C$354,556.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016David PendarvisInsiderSell6,000C$58.70C$352,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Peter C FarrellDirectorSell20,000C$57.51C$1,150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016James HollingsheadInsiderSell4,500C$58.57C$263,565.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Michael J FarrellCEOSell5,975C$58.57C$349,955.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Gary W PaceDirectorSell36,000C$60.00C$2,160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Peter C FarrellDirectorSell20,000C$57.51C$1,150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016David PendarvisInsiderSell6,000C$57.26C$343,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Anne ReiserInsiderSell1,946C$57.06C$111,038.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Brett SandercockCFOSell30,000C$57.61C$1,728,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Richard SulpizioDirectorSell36,000C$57.88C$2,083,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Peter C FarrellDirectorSell139,980C$57.31C$8,022,253.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Michael J. FarrellCEOSell5,975C$58.20C$347,745.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2016Peter C. FarrellDirectorSell20,000C$57.70C$1,154,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016David PendarvisinsiderSell6,000C$57.43C$344,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2016Franz KozichDirectorBuy60,000C$0.04C$2,100.00Tweet This Trade  Share This Trade on StockTwits
1/15/2016Michael J. FarrellCEOSell5,975C$53.07C$317,093.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016David PendarvisinsiderSell6,000C$52.16C$312,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Peter C. FarrellDirectorSell20,000C$52.22C$1,044,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Robert Andrew DouglasCOOSell6,337C$52.97C$335,670.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015James HollingsheadInsiderSell4,500C$55.95C$251,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015David PendarvisinsiderSell6,000C$59.38C$356,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Robert Andrew DouglasCOOSell6,333C$59.77C$378,523.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Warren Russell HawkinsDirectorBuy15,000C$0.06C$825.00Tweet This Trade  Share This Trade on StockTwits
11/24/2015Warren Russell HawkinsDirectorBuy3,000C$0.06C$165.00Tweet This Trade  Share This Trade on StockTwits
11/20/2015Christopher G RobertsDirectorSell12,000C$59.03C$708,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Michael J. FarrellCEOSell5,975C$57.03C$340,754.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Donald DarkininsiderSell25,442C$57.72C$1,468,512.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Robert Andrew DouglasCOOSell6,333C$57.60C$364,780.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2015Anne ReiserinsiderSell3,000C$57.01C$171,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Michael J. FarrellCEOSell5,975C$55.35C$330,716.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015David PendarvisinsiderSell5,500C$52.47C$288,585.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Robert Andrew DouglasCOOSell6,333C$52.13C$330,139.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Peter C. FarrellChairmanSell27,169C$50.93C$1,383,717.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015James HollingsheadInsiderSell4,455C$50.67C$225,734.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Michael J. FarrellCEOSell5,975C$50.89C$304,067.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015David PendarvisinsiderSell5,500C$51.78C$284,790.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Robert Andrew DouglasCOOSell6,333C$52.04C$329,569.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Peter C. FarrellChairmanSell36,000C$50.82C$1,829,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015Anne ReiserinsiderSell6,000C$52.26C$313,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Richard SulpizioDirectorSell10,860C$51.83C$562,873.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Michael J FarrellCEOSell5,975C$55.54C$331,851.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Michael J FarrellCEOSell5,975C$57.59C$344,100.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015David PendarvisInsiderSell5,500C$55.19C$303,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Peter C FarrellChairmanSell36,000C$55.61C$2,001,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Robert Andrew DouglasCOOSell6,333C$56.59C$358,384.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Michael J FarrellCEOSell5,975C$57.87C$345,773.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015David PendarvisInsiderSell5,500C$59.41C$326,755.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Peter C FarrellChairmanSell36,000C$59.25C$2,133,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Robert Andrew DouglasCOOSell6,333C$59.22C$375,040.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015David PendarvisInsiderSell5,500C$65.10C$358,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015David PendarvisInsiderSell5,500C$72.60C$399,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Peter C FarrellChairmanSell36,000C$70.70C$2,545,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Robert Andrew DouglasCOOSell6,333C$70.67C$447,553.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Warren Russell HawkinsDirectorBuy10,000C$0.09C$900.00Tweet This Trade  Share This Trade on StockTwits
3/26/2015Warren Russell HawkinsDirectorBuy10,000C$0.08C$800.00Tweet This Trade  Share This Trade on StockTwits
3/16/2015Anne ReiserInsiderSell4,000C$69.10C$276,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Michael J FarrellCEOSell5,975C$69.10C$412,872.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Anne ReiserInsiderSell3,000C$66.75C$200,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Peter C FarrellChairmanSell36,000C$64.64C$2,327,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Robert Andrew DouglasCOOSell6,333C$64.39C$407,781.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Anne ReiserInsiderSell5,000C$66.11C$330,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015David PendarvisInsiderSell5,500C$62.35C$342,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015John P WarehamDirectorSell36,000C$63.49C$2,285,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Brett SandercockCFOSell18,670C$62.82C$1,172,849.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Robert Andrew DouglasCOOSell6,333C$62.35C$394,862.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Peter C FarrellChairmanSell36,000C$61.97C$2,230,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Gary W PaceDirectorSell48,000C$66.77C$3,204,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David PendarvisInsiderSell5,500C$57.09C$313,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Peter C FarrellChairmanSell36,000C$56.99C$2,051,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Robert Andrew DouglasCOOSell8,000C$56.99C$455,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Peter C FarrellChairmanSell36,000C$53.28C$1,918,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Robert Andrew DouglasCOOSell8,000C$52.93C$423,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Peter C FarrellChairmanSell36,000C$52.39C$1,886,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014David PendarvisInsiderSell3,557C$52.00C$184,964.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Robert Andrew DouglasCOOSell8,000C$51.84C$414,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Peter C FarrellChairmanSell119,204C$51.84C$6,179,535.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014David PendarvisInsiderSell5,000C$49.84C$249,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Robert Andrew DouglasCOOSell8,000C$49.11C$392,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Michael J FarrellCEOSell3,200C$52.41C$167,712.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Brett SandercockCFOSell10,000C$52.99C$529,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Brett SandercockCFOSell10,000C$53.23C$532,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014David PendarvisInsiderSell5,000C$53.23C$266,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Anne ReiserInsiderSell3,000C$53.37C$160,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014David PendarvisInsiderSell5,000C$49.12C$245,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Peter C FarrellDirectorSell25,000C$49.04C$1,226,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Robert Andrew DouglasCOOSell8,000C$48.95C$391,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Michael J FarrellCEOSell3,200C$49.22C$157,504.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2014David PendarvisInsiderSell5,000C$50.04C$250,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Peter C FarrellDirectorSell25,000C$50.09C$1,252,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Robert Andrew DouglasCOOSell8,000C$50.11C$400,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Michael J FarrellCEOSell3,200C$53.20C$170,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014David PendarvisInsiderSell5,000C$49.76C$248,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Peter C FarrellDirectorSell25,000C$49.57C$1,239,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Robert Andrew DouglasCOOSell8,000C$50.11C$400,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Christopher G RobertsDirectorSell25,000C$49.73C$1,243,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Michael FarrellCEOSell3,700C$50.54C$186,998.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014John WarehamDirectorSell18,000C$51.00C$918,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Brett SandercockCFOSell5,000C$50.00C$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Brett SandercockCFOSell4,290C$50.00C$214,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Peter FarrellDirectorSell25,000C$49.80C$1,245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Robert Andrew DouglasCOOSell8,000C$49.75C$398,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014David PendarvisInsiderSell15,000C$50.01C$750,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2014Peter FarrellDirectorSell75,000C$48.01C$3,600,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2014David PendarvisInsiderSell5,000C$44.95C$224,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Brett SandercockCFOSell10,687C$46.00C$491,602.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Peter FarrellDirectorSell25,000C$48.00C$1,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Robert Andrew DouglasCOOSell8,000C$49.10C$392,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013Brett SandercockCFOSell15,000C$51.06C$765,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013James HollingsheadInsiderSell4,000C$51.24C$204,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Donald DarkinInsiderSell31,063C$50.04C$1,554,392.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013David PendarvisInsiderSell37,744C$50.42C$1,903,052.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Peter C FarrellDirectorSell25,000C$53.21C$1,330,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Robert Andrew DouglasCOOSell8,000C$53.20C$425,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Gary W PaceDirectorSell12,000C$50.05C$600,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Peter C FarrellDirectorSell25,000C$48.00C$1,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Robert Andrew DouglasCOOSell8,000C$47.51C$380,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Michael QuinnDirectorSell48,000C$48.34C$2,320,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Brett SandercockCFOSell5,000C$49.00C$245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Christopher RobertsDirectorSell10,000C$49.49C$494,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Robert Andrew DouglasCOOSell8,000C$48.57C$388,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Robert Andrew DouglasCOOSell8,000C$47.96C$383,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Christopher G RobertsDirectorSell20,000C$49.45C$989,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013John P WarehamDirectorSell18,000C$50.20C$903,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Michael A QuinnDirectorSell15,000C$50.94C$764,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Brett SandercockCFOSell28,000C$48.97C$1,371,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Robert Andrew DouglasCOOSell8,000C$44.14C$353,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Michael J FarrellInsiderSell30,000C$35.58C$1,067,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for ResMed (NYSE:RMD)
DateHeadline
06/30/16 08:58 AMResMed Inc. (NYSE:RMD) Company Rating and Target Watch - Telanagana Press
06/29/16 08:54 AMMatthews International Capital Management LLC Increased Resmed INC (NYSE:RMD) by $69.41 Million as Shares Rose - Engelwood Daily
06/29/16 08:54 AMResMed Inc. (RMD) is Trading Lower on Unusual Volume for June 27 - Equities.com
06/28/16 06:03 PMResMed Inc. : Median Sales Estimate At $546.65
06/28/16 08:11 AMResMed Awarded Group Purchasing Contract with Premier - [at noodls] - SAN DIEGO, June 28, 2016 /PRNewswire/ -- ResMed (NYSE:RMD), the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced it has ...
06/28/16 07:02 AMTop Stock Pick for Quarter: ResMed Inc. (NYSE:RMD) - Engelwood Daily
06/27/16 10:19 AMResMed Inc. (NYSE:RMD) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 05:35 PMStock Performance Focus on: ResMed Inc. (NYSE:RMD) - Press Telegraph
06/25/16 09:52 AMHow Analysts Feel About ResMed Inc. (NYSE:RMD)? - Press Telegraph
06/24/16 08:45 AM5 ASX shares to beat the Brexit sell off
06/23/16 08:48 AMResMed (NYSE:RMD) Analyst Rating Consensus - TheFounders Daily
06/23/16 08:48 AMResMed Inc. (RMD) is Trading Higher on Unusual Volume for June 21 - Equities.com
06/22/16 06:05 PM6 investing trends to help smart investors smash the market
06/21/16 05:42 PMResMed Inc. (NYSE:RMD) Upside Stock Momentum at Extreme Strength - CML News
06/20/16 08:09 AMResMed Statement on Brightree Executive Appointments - [at noodls] - SAN DIEGO, June 20, 2016 /PRNewswire/ -- ResMed (NYSE:RMD) today issued the following statement related to Brightree's announcement of its new executive team, from president of healthcare informatics Raj ...
06/20/16 07:15 AMResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : June 20, 2016 -
06/19/16 09:56 AMResMed Inc. (NYSE:RMD): The Buzzing Stock - Stocks Daily
06/14/16 05:53 PMResMed Inc. (NYSE:RMD) To Report June 2016 Results - iStreetWire
06/13/16 09:05 AMComplete Analysis of: TimkenSteel Corporation (NYSE:TMST), ResMed Inc. (NYSE:RMD) - Beacon Chronicle
06/13/16 08:09 AMKaiser Permanente Study: ResMed Digital Platform Drives CPAP Adherence - [at noodls] - DENVER, June 13, 2016 /PRNewswire/ -- Remote monitoring and automated coaching from ResMed (NYSE: RMD) significantly improve the use of continuous positive airway pressure therapy for patients with obstructive ...
06/09/16 04:27 PMRESMED INC Files SEC form 8-K/A, Financial Statements and Exhibits -
06/07/16 06:25 PMRESMED INC. (NYSE:RMD) Financial Condition Compared to S&P 500 - CML News
06/02/16 09:11 AMStock Review and Earnings Check on ResMed Inc. (NYSE:RMD) - HNN - Stock Review and Earnings Check on ResMed Inc. (NYSE:RMD)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting ResMed Inc. (NYSE:RMD) to report ...and more »
06/01/16 06:44 PMStrong Sell Calls Count For ResMed Inc. (NYSE:RMD) At 2 - Investor Newswire - Strong Sell Calls Count For ResMed Inc. (NYSE:RMD) At 2Investor NewswireResMed Inc. (NYSE:RMD) has a total of 1 Strong Buy calls and 2 Strong Sell advises as of 2016-05-31. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is considered to be a buy ...and more »
06/01/16 09:03 AMAnalysts Rating Alert: MannKind Corporation (NASDAQ:MNKD) , ResMed Inc. (NYSE:RMD) - Street Updates - Analysts Rating Alert: MannKind Corporation (NASDAQ:MNKD) , ResMed Inc. (NYSE:RMD)Street UpdatesIn the past trading session, ResMed Inc. (NYSE:RMD) highlighted upward shift of +1.06% or +0.62 points to $59.06. The company traded a volume of 2.01 million shares over average volume of 972.44 thousand shares. Trailing twelve month period, the firm ...and more »
05/31/16 09:43 AMTrading Overview of Two Stocks: NuVasive, Inc. (NASDAQ:NUVA) , ResMed Inc. (NYSE:RMD) - Street Updates - Trading Overview of Two Stocks: NuVasive, Inc. (NASDAQ:NUVA) , ResMed Inc. (NYSE:RMD)Street UpdatesResMed Inc. (NYSE:RMD) after beginning at $58.13, closed at $58.44 by building up +0.38% in recent trading session. Most recent session's volume of 552.48 thousand shares lower than its average volume of 967.44 thousand shares. The company has ...and more »
05/29/16 10:54 PMResMed : Van Hulzen Asset Management LLC Decreased Stake in Resmed by $3.01 Million as Shares Rose - The stock is down 0.02% or $0.01 after the negative news, hitting $58.21 per share. ResMed Inc. (NYSE:RMD) has risen 3.58% since October 21, 2015 and is uptrending. It has outperformed by 0.05% the S&P500. Van Hulzen Asset Management Llc is a California ...
05/28/16 10:58 PMPerformance at a Glance on ResMed Inc. (NYSE:RMD) - HNN - Performance at a Glance on ResMed Inc. (NYSE:RMD)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how ResMed Inc. (NYSE:RMD)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/26/16 09:20 AMEarnings Review and Stock Rundown for ResMed Inc. (NYSE:RMD) - Wall Street Hints and News - Earnings Review and Stock Rundown for ResMed Inc. (NYSE:RMD)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting ResMed Inc. (NYSE:RMD) to post quarterly ...and more »
05/26/16 09:20 AMTraders Attention Alert: ResMed Inc. (NYSE:RMD) , Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) - Street Updates - Traders Attention Alert: ResMed Inc. (NYSE:RMD) , Aralez Pharmaceuticals Inc (NASDAQ:ARLZ)Street UpdatesOn 5/25/2016, shares of ResMed Inc. (NYSE:RMD) fell -0.71% in trading session and finally closed at $57.72. The company most recent volume stood at 940.33 thousand shares as compared to its average volume of 974.13 thousand shares. Over the one ...
05/26/16 07:35 AMResMed Posts Mixed Q3 Results, Brightree Buyout on Track -
05/25/16 11:01 PMStock Rating Review for ResMed Inc. (NYSE:RMD) - Wall Street Hints and News - Stock Rating Review for ResMed Inc. (NYSE:RMD)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 3.06 on shares of ResMed Inc. (NYSE:RMD). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is compiled ...and more »
05/25/16 05:51 PMHigh Quality Guru Stocks: EMC, Bed Bath & Beyond - ResMed Inc. (RMD) GuruFocus gives the company a business predictability of 4.5 out of 5 stars. It is a developer, manufacturer and distributor of medical products for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders.
05/25/16 07:51 AMResMed: Positive CAT-HF Study Results to Drive ASV Sales -
05/23/16 11:04 PMResMed : Matthews International Capital Management buys $70.3 Million stake in ResMed (RMD) - ResMed makes up approx 0.04% of Swiss National Banks portfolio.Commonwealth Equity Services Inc reduced its stake in RMD by selling 54 shares or 1.0% in the most recent quarter. The Hedge Fund company now holds 5,359 shares of RMD which is valued at $299,032.
05/23/16 10:56 AMShares Trading up at $57.62 Adaptive Servo-ventilation (ASV) Therapy… - ResMed Inc. Common Stock (NYSE:RMD): Adaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular Outcomes for People with Sleep-Disordered Breathing and Heart Failure With Preserved Ejection Fraction In Phase II Study. The company is now up ...
05/22/16 05:23 PMAfter Last Week What Do Analysts Think Of ResMed Inc. (NYSE:RMD) - Share Trading News - After Last Week What Do Analysts Think Of ResMed Inc. (NYSE:RMD)Share Trading News10/24/2014 – ResMed Inc. was upgraded to “outperform” by analysts at William Blair. The share price of ResMed Inc. (NYSE:RMD) was up +1.37% during the last trading session, with a day high of 57.72. 778504 shares were traded on ResMed Inc.'s last ...
05/22/16 10:35 AMResMed Inc. (NYSE:RMD) One-Year Price Projection At $56.2 - Investor Newswire - ResMed Inc. (NYSE:RMD) One-Year Price Projection At $56.2Investor NewswireSell-side analysts are certain on the prospect of ResMed Inc. (NYSE:RMD) stock. As of 2016-05-21, the stock ABR stands at 3.06. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such stocks ...and more »
05/22/16 01:40 AMAdaptive Servo-ventilation (ASV) Therapy Suggests Positive Cardiovascular Outcomes for People with Sleep-Disordered Breathing and Heart Failure With Preserved Ejection Fraction In Phase II Study - [PR Newswire] - FLORENCE, Italy, May 22, 2016 /PRNewswire/-- ResMed (RMD) today announced primary results from a multicenter, randomized controlled Phase II trial known as CAT-HF presented at the European Society of Cardiology's 2016 Annual Heart Failure Congress. CAT-HF assessed whether the treatment of moderate to severe sleep-disordered breathing (obstructive or central sleep apnea) with adaptive servo-ventilation (ASV) therapy could improve cardiovascular outcomes in patients who were hospitalized for a sudden worsening of their heart failure symptoms (acute decompensated heart failure) over six months.
05/21/16 05:32 PMPerformance at a Glance on ResMed Inc. (NYSE:RMD) - Wall Street Hints and News - Performance at a Glance on ResMed Inc. (NYSE:RMD)Wall Street Hints and NewsWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how ResMed Inc. (NYSE:RMD)'s stock has performed at various points in its past. Currently, the stock ...and more »
05/21/16 09:22 AMAre Analysts Bearish ResMed Inc. (NYSE:RMD) After Last Week? - Wall Street Hints and News - Are Analysts Bearish ResMed Inc. (NYSE:RMD) After Last Week?Wall Street Hints and NewsOut of 11 analysts covering ResMed Inc (NYSE:RMD), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. ResMed Inc has been the topic of 12 analyst reports since August 3, 2015 according to StockzIntelligence Inc. Below is a list ...and more »
05/20/16 05:52 PMBroker Roundup For ResMed Inc. (NYSE:RMD) - Share Trading News - Broker Roundup For ResMed Inc. (NYSE:RMD)Share Trading News10/24/2014 – ResMed Inc. was upgraded to “outperform” by analysts at William Blair. The share price of ResMed Inc. (NYSE:RMD) was up +1.00% during the last trading session, with a day high of 57.72. 119477 shares were traded on ResMed Inc.'s last ...
05/20/16 09:34 AMShare Recap and Earnings Focus on ResMed Inc. (NYSE:RMD) - Wall Street Hints and News - Share Recap and Earnings Focus on ResMed Inc. (NYSE:RMD)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating ResMed Inc. (NYSE:RMD) to ...and more »
05/18/16 11:02 PMAnalyst Rating Check on ResMed Inc. (NYSE:RMD) - Wall Street Hints and News - Analyst Rating Check on ResMed Inc. (NYSE:RMD)Wall Street Hints and NewsCurrently, sell-side analysts have provided a consensus stock rating of 3.06 on shares of ResMed Inc. (NYSE:RMD). Analysts that cover the company will usually offer Buy, Sell, or Hold recommendations based on in-depth research. This consensus number is ...and more »
05/18/16 09:49 PMETF’s with exposure to ResMed, Inc. : May 19, 2016 -
05/17/16 05:45 PMResMed Inc. (NYSE:RMD) Annual EPS Anticipated At $0.79 - Investor Newswire - Street RegisterResMed Inc. (NYSE:RMD) Annual EPS Anticipated At $0.79Investor NewswireAs of 2017-06-30, Zacks released mean EPS target of $0.79 for ResMed Inc. (NYSE:RMD) for the year ended 2017. Median EPS forecast is set at $0.79. The forecast is calculated on basis of 4 forecasts. This count also accounts the research reports of 5 ...ResMed Inc. (NYSE:RMD) Upcoming Earnings: What matter for investors?Street RegisterResMed Inc. (NYSE:RMD) Reports Basic Consolidated EPS At $2.5122Equities FocusResmed Incorporated (NYSE:RMD) Short Interest Decreased By 0.17%Franklin IndependentFinance Dailyall 5 news articles »
05/17/16 09:47 AMMatthews International Capital Management LLC Increased Resmed INC (NYSE:RMD) by $69.41 Million as Shares Rose - CCH Daily News - Matthews International Capital Management LLC Increased Resmed INC (NYSE:RMD) by $69.41 Million as Shares RoseCCH Daily NewsMatthews International Capital Management Llc increased its stake in Resmed Inc (NYSE:RMD) by 18735.38% based on its latest 2016Q1 regulatory filing with the SEC. Matthews International Capital Management Llc bought 1.22M shares as the company's ...and more »
05/17/16 07:18 AMResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : May 17, 2016 -
05/16/16 10:45 PMResMed Inc. (NYSE:RMD) Upcoming Earnings: What matter for investors? - Street Register - Street RegisterResMed Inc. (NYSE:RMD) Upcoming Earnings: What matter for investors?Street RegisterResMed Inc. (RMD) retreated -0.64% to reach at the floor price of $57.44 as the company is set to share its next quarterly earnings on July 28, 2016. RMD stock trades between $57.11 and $57.74 before the earnings release. Let's take a closer look at ...and more »
05/16/16 05:38 PMResMed Inc. (RMD) Ex-Dividend Date Scheduled for May 17, 2016 - Nasdaq - ResMed Inc. (RMD) Ex-Dividend Date Scheduled for May 17, 2016NasdaqResMed Inc. ( RMD ) will begin trading ex-dividend on May 17, 2016. A cash dividend payment of $0.3 per share is scheduled to be paid on June 16, 2016. Shareholders who purchased RMD prior to the ex-dividend date are eligible for the cash dividend ...
About ResMed

ResMed logoResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: RMD
  • CUSIP: 76115210
Key Metrics:
  • Previous Close: $62.03
  • 50 Day Moving Average: $59.20
  • 200 Day Moving Average: $57.45
  • P/E Ratio: 25.34
  • P/E Growth: 2.23
  • Market Cap: $8.68B
  • Current Quarter EPS Consensus Estimate: $2.65 EPS
Additional Links:
ResMed (NYSE:RMD) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha